Tamarly Intelligence
Company · EVMN (New York Stock Exchange, Inc.)

Evommune, Inc.

Pharmaceutical Preparations

Key figures
Industry
Pharmaceutical Preparations (SIC 2834)
Institutional holders
105 at 30 Jun 2026 (84 the quarter before)
SEC number
2044725

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 14 Oct 2026

Latest filings
1 Oct 2026
8-K 8-K
23 Sept 2026
8-K 8-K
15 Sept 2026
8-K 8-K
9 Sept 2026
8-K 8-K
6 Aug 2026
10-Q 10-Q

Source: SEC EDGAR

With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Evommune, Inc.: EVMN, filings, holders and country risk | Tamarly